Tumor-Specific 3D Cell Culture Models for Accurate Testing of Anticancer Agents

Labcorp (formerly Covance) offers zPREDICTA's human reconstructed platforms with tissue specific tumor microenvironments as well as exclusive mouse platforms. This webinar explores how 3D cultures can be maintained long term to better mimic disease progression and provide a window for efficacy evaluation. How multiple types of assay readouts can be done within the 3D models including isolated spheroids for flow cytometry, cytokine levels and immunohistochemistry; while multiple types of therapeutic agents can be screened in 3D models, including small molecules, antibodies, and CAR T cells. Learn more about how 3D tissue specific tissue matrix can be predictive of in vivo response and used as a tool to speed the development of candidates between early discovery and final in vivo efficacy testing.

Copy and paste this URL:

https://biopharma.Labcorps.co.uk/latest-thinking/explore-library/detail.html/covance/assetLibrary/videos/Tumor-Specific-3D-Models-Accurate-Testing-Anticancer-Agents-VIDED011.png